Gene Therapy of Cancer EBOOK Translational Approaches from Preclinical Studies to Clinical Implementation

  • Engels
  • E-book
  • 9780123946324
  • Druk: 3
  • augustus 2013
  • 816 pagina's
  • -72234
Alle productspecificaties
  • bol.com Kobo LeesappEbooks lezen is heel makkelijk. Na aankoop zijn ze direct beschikbaar op je Kobo e-reader en op je smartphone of tablet met de gratis bol.com Kobo app.

Samenvatting

Gene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical and clinical studies have led to the design and testing of new therapeutic approaches. The Third Edition of Gene Therapy of Cancer provides crucial updates on the basic and applied sciences of gene therapy. It offers a comprehensive assessment of the field including the areas of suicide gene therapy, oncogene and suppressor gene targeting, immunotherapy, drug resistance gene therapy, and the genetic modification of stem cells. Researchers at all levels of development, from basic laboratory investigators to clinical practitioners, will find this book to be instructive.

Cancer gene therapy, like cancer therapy in general, is evolving rapidly, testing new concepts, targets and pathways, evoking new technologies, and passing new regulatory hurdles. Its essence, however, has not changed: the hope and challenges of returning altered genes to normal, using targeted gene expression to alter the function of both tumor and microenvironment, and in some cases normal cells, and delivering functionally important genes to specific cell types to increase sensitivity to killing or to protect normal cells from cancer therapies.

In some instances, gene therapy for cancer forms a continuum from gene repair through the use of molecularly modified cells; the use of viral and non-viral vector based gene delivery to both tumor and tumor microenvironment; the use of viral and gene based vaccines; and development of new gene-based therapeutics. The unique mechanistically chosen vector platforms are at the heart of this technology because they allow for direct and selective cell death and transient to sustained delivery of vaccine molecules or molecules that affect the microenvironment, vasculature, or the immune response.

  • Explains the underlying cancer biology necessary for understanding proposed therapeutic approaches
  • Presents in-depth description of targeting systems and treatment strategies
  • Covers the breadth of gene therapy approaches including immunotherapeutic, drug resistance,oncolytic viruses, as well as regulatory perspectives from both the NCI and FDA

Lees de eerste pagina's

Productspecificaties

Inhoud

Taal
Engels
Bindwijze
E-book
Druk
3
Verschijningsdatum
augustus 2013
Aantal pagina's
816 pagina's
Ebook formaat
-72234
Illustraties
Nee

Betrokkenen

Auteur
Edmund Lattime Stanton L. Gerson
Co-auteur
Stanton L. Gerson
Redacteur
Edmund C. Lattime
Co-redacteur
Stanton L. Gerson, Md
Uitgever
Academic Press

Lees mogelijkheden

Lees dit ebook op
Android (smartphone en tablet) | Kobo e-reader | Overige e-reader | Desktop (Mac en Windows) | iOS (smartphone en tablet) | Windows (smartphone en tablet)
Ebook formaat
-72234

EAN

EAN
9780123946324

Overige kenmerken

Extra groot lettertype
Nee
Gewicht
1860 g
Verpakking breedte
216 mm
Verpakking hoogte
276 mm
Verpakking lengte
276 mm

Je vindt dit artikel in

Categorieën
Taal
Engels
Boek, ebook of luisterboek?
Ebook
Nog geen reviews